logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jukka Westerbacka

IRCCS Ca Granda Ospedale Maggiore Policlinico

51H指数
218论文数
1.0W被引数
收录论文 76
发表时间
logo
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial基于连续血糖监测的血糖达标时间：1型糖尿病患者中甘精胰岛素300 U/ml与德谷胰岛素100 U/ml的头对头随机对照In Range试验
errDIABETES OBESITY & METABOLISM
IF5.7
err2022-11-14
err26
errOAAI
errBattelino, Tadej; Danne, Thomas; Edelman, Steve, V; Choudhary, Pratik; Renard, Eric; Westerbacka, Jukka; Mukherjee, Bhaswati; Pilorget, Valerie; Coudert, Mathieu; Bergenstal, Richard M.
err分享
err收藏
Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D-The InRange Randomized Controlled Trial
errDIABETES
IF7.5
err2022-06-01
err1
PREAI
errBergenstal, Richard M.; Edelman, Steven; Choudhary, Pratik; Danne, Thomas; Renard, Eric; Westerbacka, Jukka; Mukherjee, Bhaswati; Picard, Pascaline; Pilorget, Valerie; Battelino, Tadej
err分享
err收藏
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G study
errDIABETES OBESITY & METABOLISM
IF5.7
err2022-05-26
err4
errOAAI
errBailey, Timothy S.; Gill, Jasvinder; Jones, Merwyn S.; Shenoy, Laxmi; Nicholls, Charlie; Westerbacka, Jukka
err分享
err收藏
Real-world outcomes in people with type 2 diabetes (PWD2) and renal impairment receiving insulin glargine 300 U/mL (Gla-300) and insulin degludec 100U/mL or 200U/mL (IDeg): the DELIVER-R study
errMETABOLISM-CLINICAL AND EXPERIMENTAL
IF11.9
err2022-03-01
err0
PREAI
errBailey, Timothy; Urquhart, Scott; Westerbacka, Jukka; Gill, Jasvinder; Nicholls, Charlie
err分享
err收藏
A review of reusable insulin pens and features of TouStar-a new reusable pen with a dedicated cartridge
errDIABETOLOGY & METABOLIC SYNDROME
IF3.9
err2021-12-19
err2
errOAAI
errVeasey, Robert; Ruf, Carolin A.; Bogatirsky, Dmitri; Westerbacka, Jukka; Friedrichs, Arnd; Abdel-Tawab, Mona; Adler, Steffen; Mohanasundaram, Senthilnathan
err分享
err收藏
Real-World Outcomes of Addition of Insulin Glargine 300 U/mL (Gla-300) to GLP-1RA Therapy in People with Type 2 Diabetes (PWD2): The DELIVER-G Study
errDIABETES
IF7.5
err2021-06-01
err0
PREAI
errBailey, Timothy S.; Westerbacka, Jukka; Nicholls, Charlie; Gill, Jasvinder; Jones, Merwyn; Shenoy, Laxmi
err分享
err收藏
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
errDIABETES OBESITY & METABOLISM
IF5.7
err2021-04-01
err7
errOAAI
errBolli, Geremia B.; Cheng, Alice; Charbonnel, Bernard; Aroda, Vanita R.; Westerbacka, Jukka; Bosnyak, Zsolt; Boelle-Le Corfec, Emmanuelle; Rosenstock, Julio
err分享
err收藏
How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting?
errDIABETES OBESITY & METABOLISM
IF5.7
err2020-12-18
err4
errOAAI
errMauricio, Didac; Westerbacka, Jukka; Nicholls, Charlie; Wu, Jasmanda; Gupta, Rishab; Eliasson, Bjorn
err分享
err收藏
Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)
errDIABETES
IF7.5
err2020-06-01
err0
PREAI
errHarris, Stewart B.; Snoek, Frank J.; Meneghini, Luigi; Lauand, Felipe, Sr.; Westerbacka, Jukka; de Climens, Aude Roborel; Khunti, Kamlesh
err分享
err收藏
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial
errDIABETES OBESITY & METABOLISM
IF5.7
err2020-04-28
err31
errOAAI
errHaluzik, Martin; Cheng, Alice; Mueller-Wieland, Dirk; Westerbacka, Jukka; Bosnyak, Zsolt; Lauand, Felipe; Melas-Melt, Lydie; Karalliedde, Janaka; Rosenstock, Julio; Bolli, Geremia B.
err分享
err收藏
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study用甘精胰岛素300单位/mL和degludec 100单位/mL开始胰岛素后，在主动滴定期间，血糖控制相似，低血糖减少: BRIGHT研究的子分析
errDIABETES OBESITY & METABOLISM
IF5.7
err2019-12-20
err5
errOAAI
errCheng, Alice; Harris, Stewart; Giorgino, Francesco; Seufert, Jochen; Ritzel, Robert; Khunti, Kamlesh; Lauand, Felipe; Melas-Melt, Lydie; Westerbacka, Jukka; Bosnyak, Zsolt; Rosenstock, Julio
err分享
err收藏
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3)
errDIABETES OBESITY & METABOLISM
IF5.7
err2019-07-18
err27
errOAAI
errBailey, Timothy S.; Wu, Jasmanda; Zhou, Fang L.; Gupta, Rishab A.; Menon, Arjun A.; Berhanu, Paulos; Westerbacka, Jukka; Van Vleet, John; Blonde, Lawrence
err分享
err收藏
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naive D real-world study
errDIABETES OBESITY & METABOLISM
IF5.7
err2019-06-21
err26
errOAAI
errSullivan, Sean D.; Nicholls, Charlie J.; Gupta, Rishab A.; Menon, Arjun A.; Wu, Jasmanda; Westerbacka, Jukka; Bosnyak, Zsolt; Frias, Juan P.; Bailey, Timothy S.
err分享
err收藏
Predictive Modeling Suggests Subgroup Effects for Severe Hypoglycemia in T2DM Patients Treated with Gla-300 vs. IDeg: The LIGHTNING Study
errDIABETES
IF7.5
err2019-06-01
err0
PREAI
errHramiak, Irene; Haluzik, Martin; Westerbacka, Jukka; Bosnyak, Zsolt; Eliasson, Bjorn; Blonde, Lawrence; Bailey, Timothy S.
err分享
err收藏
High Hypoglycemia Risk Patients with T2D on First-Generation Basal Insulins (BI) in the US Have a Lower Risk of Hypoglycemia after One Year following Switch to Insulin Glargine 300 U/mL (Gla-300) vs. First-Generation BIs (DELIVER - High Risk)
errDIABETES
IF7.5
err2019-06-01
err1
PREAI
errSullivan, Sean D.; Freemantle, Nick; Menon, Arjun A.; Gupta, Rishab; Wu, Jasmanda; Nicholls, Charlie; Westerbacka, Jukka; Bailey, Timothy S.
err分享
err收藏
Differences in HbA1c Reduction between Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (IDeg-100) in Adults ≥70 Years of Age with T2DM in the BRIGHT Trial
errDIABETES
IF7.5
err2019-06-01
err4
PREAI
errCharbonnel, Bernard; Aroda, Vanita R.; Westerbacka, Jukka; Lauand, Felipe, Sr.; Boelle, Emmanuelle; Cheng, Alice Y.; Rosenstock, Julio; Bolli, Geremia B.
err分享
err收藏
Reaching ADA Glycemic Targets without Hypoglycemia during Titration with Gla-300 and IDeg in T2DM: Exploratory Analyses from BRIGHT
errDIABETES
IF7.5
err2019-06-01
err0
PREAI
errRoussel, Ronan; Frias, Juan P.; Westerbacka, Jukka; Bosnyak, Zsolt; Melas-Melt, Lydie; Berard, Lori; Cheng, Alice Y.
err分享
err收藏
Treatment Satisfaction with Gla-300, IDeg-100, and Gla-100 in Insulin-Naive T2DM: The BRIGHT and EDITION 3 Trials
errDIABETES
IF7.5
err2019-06-01
err0
PREAI
errBerard, Lori; Snoek, Frank J.; Harris, Stewart B.; Westerbacka, Jukka; Bosnyak, Zsolt; Melas-Melt, Lydie; Khunti, Kamlesh
err分享
err收藏
Early Hypoglycemia after Initiation of Second-Generation Basal Insulin (BI) Analogs: Patient Characteristics and Clinical Outcomes
errDIABETES
IF7.5
err2019-06-01
err1
PREAI
errHarris, Stewart B.; Berard, Lori; Westerbacka, Jukka; Bosnyak, Zsolt; Melas-Melt, Lydie; Lauand, Felipe, Sr.; Bailey, Timothy S.; Khunti, Kamlesh
err分享
err收藏
The Forgotten Populations: Real-World Patients with T2DM Not Meeting Eligibility Criteria of the Glargine 300 U/ml EDITION and BRIGHT RCTs
errDIABETES
IF7.5
err2019-06-01
err1
PREAI
errMauricio, Didac; Westerbacka, Jukka; Nicholls, Charlie; Wu, Jasmanda; Gupta, Rishab; Menon, Arjun A.; Eliasson, Bjorn
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
K
Kamlesh Khunti
H 指数: 162 · 论文数: 2.1K
V
Vincenzo Di Marzo
H 指数: 158 · 论文数: 1.2K
L
Leif Groop
H 指数: 155 · 论文数: 1.0K
S
Steve E. Humphries
H 指数: 140 · 论文数: 1.5K
A
Anders Hamsten
H 指数: 135 · 论文数: 1.0K
查看更多